Clinical trial · Interventional
Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In this research, we will evaluate the feasibility of following by remote monitoring, using a connected scale, in hematology patients suffering from myeloma or lymphoma and requiring treatment with chemotherapy. 30 patients will be included in the research and will all use a connected scale for the duration of their participation (7 weeks +/- 1 week). During their participation, patients will be asked to weigh themselves once a day, ideally at a set time. Patient data will be accessible by the medical team via a remote monitoring platform. Alerts will be generated in the event of abnormal development of certain clinical parameters (weight, heart rate, etc.) allowing early treatment to be implemented by the medical team. At the end of their participation, we will evaluate patients' support and perception of this tool, as well as the healthcare consequences of the alerts generated by the remote monitoring platform.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lymphoma, Non-Hodgkin | Non-Hodgkin Lymphoma | ONTOLOGY_EXACT | 0.90 |
| Myeloma Multiple | Multiple Myeloma | PROBABILISTIC | 0.70 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Connected scale "Body Comp Pro" from Withings | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Cohort group
- description
- Patients will be used a connected scale during the duration of their participation in the study. Patients will be invited to use the scale once a day. Patient's data will be accesible by medical team via a specific remote plateform. Alert will be generated according to the evolution of clinical data, permetting a early patient management by the medical team.
- interventionNames
- Device: Connected scale "Body Comp Pro" from Withings
Primary outcomes (1)
- measure
- Percentage of patients who agreed to participate in research
- timeFrame
- Inclusion
- description
- Number of included patients / Number of indormed patients
Secondary outcomes (8)
- measure
- Frequency of use of the connected scale during the patient's participation in the research
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient aged 18 and over (male or female) * Patient suffering from aggressive non-Hodgkin's lymphoma or multiple myeloma with a plan for systemic chemotherapy or having started two cycles or less or patient with the need for therapeutic intensification under the cover of autograft in the context of myeloma or lymphoma * Patient who can be contacted by telephone during their participation in the research * Patient able to return home at the end of their initial hospitalization * Patient affiliated to social security * Patient able to read and speak French * Patient having signed free, informed and written consent Exclusion Criteria: * Patient with an estimated life expectancy \< 3 months * Patient with moderate to severe cognitive impairment (assessed by MMSE \< 20) * Patient with a psychiatric or physical disability that does not allow the use of the device * Patient with a pacemaker * Patient participating in another intervention research project * Pregnant patient * Patient deprived of liberty * Patient under legal protection (guardianship or curatorship)
References
Publications (0)
Data not yet available